<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01712152</url>
  </required_header>
  <id_info>
    <org_study_id>EK 11-228- 0112</org_study_id>
    <nct_id>NCT01712152</nct_id>
  </id_info>
  <brief_title>Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Rudolfstiftung</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oesterreichische Muskelforschung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Rudolfstiftung</source>
  <brief_summary>
    <textblock>
      Carriers of Duchenne muscular dystrophy (DMD) often have no severe symptoms of the scelet
      muscles, but they may develop a poor heart function due to the involvement of the heart
      muscle. Ultrasound of the heart is recommended, but it can detect a cardiac affection only
      after the heart has already become weaker. Cardiac magnetic resonance tomography can detect
      myocardial fibrosis already at preserved heart function and may facilitate early therapy. In
      our study, diagnosed carriers of DMD will undergo examinations of the heart by blood tests,
      EKG, heart ultrasound and magnetic resonance at enrollment and after one year in order to
      assess the extent of cardiac affection and its association with the clinical development.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>T1 mapping</measure>
    <time_frame>1 year</time_frame>
    <description>T1 mapping by MOLLI sequences will be performed and compared between study entry and one year follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>left ventricular function</measure>
    <time_frame>1 year</time_frame>
    <description>left ventricular function on MRI will be compared between study entry and one year follow-up</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Carrier of Duchenne Muscular Dystrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        data base of carriers of Duchenne muscular dystrophy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        genetic and/or histological identification as a carrier of DMD age above 18 years able and
        willing to conform to the requirements of the study provided written informed consent
        exclusion of pregnancy in women of childbearing potential

        Exclusion Criteria:

        Claustrophobia Excessive obesity to an extent where CMR cannot be performed Chronic renal
        failure with a GFR &lt;30 ml/min/1,73mÂ² Implanted pacemakers/defibrillators Severe arrhythmia
        Inability to cooperate during the CMR Known intolerance to gadolinium Positive pregnancy
        test Unable or unwilling to conform to the study protocol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Wexberg, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Rudolfstiftung</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>2nd Medical Dept., Rudolfstiftung</name>
      <address>
        <city>Vienna</city>
        <zip>A-1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2012</study_first_submitted>
  <study_first_submitted_qc>October 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2012</study_first_posted>
  <last_update_submitted>October 3, 2016</last_update_submitted>
  <last_update_submitted_qc>October 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Rudolfstiftung</investigator_affiliation>
    <investigator_full_name>Paul Wexberg,MD</investigator_full_name>
    <investigator_title>Priv.-Doz.</investigator_title>
  </responsible_party>
  <keyword>Duchenne muscular dystrophy</keyword>
  <keyword>carrier</keyword>
  <keyword>cardiac MRI</keyword>
  <keyword>myocardial fibrosis</keyword>
  <keyword>female</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

